Inactive Instrument

News KV Pharmaceutical Co Other OTC

Equities

US4827401070

End-of-day quote Other OTC Other stock markets
- ^USD	-

2012

K-V Pharmaceutical Company : K-V Pharmaceutical files for bankruptcy protection

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

KV Pharmaceutical Co : Ther-Rx Corporation and Perrigo Company Announce the Availability of Gynazole-1® (Butoconazole Nitrate Vaginal Cream USP, 2%) for Prescribing	13-01-25	PU
KV Pharmaceutical Co : K-V Pharmaceutical Receives Court Approval of Hologic Settlement	13-01-01	PU
KV Pharmaceutical Co : K-V Pharmaceutical Secures Commitment for $85 Million Loan, Reaches Agreement with Senior Noteholders on Principal Terms of Plan of Reorganization	12-12-19	PU
K-V Pharmaceutical Company : K-V Pharmaceutical Use of Cash Collateral Approved by U. S. Bankruptcy Court	12-08-10	PU
K-V Pharmaceutical Company : K-V Pharmaceutical "First Day" Motions Approved by U.S. Bankruptcy Court	12-08-08	PR
K-V Pharmaceutical Company : K-V Pharmaceutical Announces Planned Transition of Trading of Class A and Class B Common Shares to the OTC Markets	12-08-06	PU
K-V Pharmaceutical Company : K-V Pharmaceutical files for bankruptcy protection	12-08-04	RE
K-V Pharmaceutical Company : Files Voluntary Petitions for Reorganization to Restructure Financial Obligations	12-08-04	PU
K-V Pharmaceutical Company : Announces Additional Notification from NYSE Regarding Listing Criteria	12-07-20	PR
K-V Pharmaceutical Company : Announces Notification from NYSE Regarding Listing Criteria	12-06-29	PR
K-V Pharmaceutical Company : to Present at Imperial Capital 2012 Healthcare Investor Forum	12-04-12	PR
K-V Pharmaceutical Company : to Present at Needham & Company 11th Annual Healthcare Conference	12-04-02	PR
K-V Pharmaceutical Company : K-V Pharmaceutical Announces Updated Makena® Performance Metrics and Investor Conference Call	12-02-09	PR
K-V Pharmaceutical Company : Comments on Recent Settlement with the Department of Justice	11-12-07	PU
K-V Pharmaceutical Company : Independent Laboratory Testing Demonstrates Important Quality Differences Between FDA-Approved Makena® and Compounded 17P Formulations	11-11-08	PU
K-V Pharmaceutical Company : K-V Pharmaceutical Announces Updated Makena® Performance Metrics	11-11-08	PR
KV PHARMA'A' : K-V PHARMACEUTICAL COMMENTS ON ACOG AND SMFM INFORMATION UPDATE REGARDING 17-ALPHA HYDROXYPROGESTERONE CAPROATE – FDA-APPROVED MAKENA™ AND COMPOUNDED 17P	11-10-13	PU
KV PHARMA'A' : K-V Pharmaceutical Company to Present at Imperial Capital's 5th Annual Global Opportunities Conference	11-09-28	PR
KV PHARMA'A' : K-V PHARMACEUTICAL COMPANY ANNOUNCES THE COMPLETION OF THE SALE OF NESHER PHARMACEUTICALS, INC. ITS GENERIC PHARMACEUTICAL BUSINESS	11-08-09	PU
KV PHARMA'A' : K-V Pharmaceutical Company Announces Filing of First Quarter Fiscal 2012 Form 10-Q and Schedules Investor Conference Call	11-08-09	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News KV Pharmaceutical Co Other OTC

Equities

US4827401070

Summary

Filters